GCN

DEAD

Serial Number

87307659

Owner

Orexigen Therapeutics, Inc.

Attorney

Andrew N. Spivak

Filing Date

Jan 19, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

GCN Trademark

Serial Number: 87307659

GCN is a trademark filed by Orexigen Therapeutics, Inc. on January 19, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Orexigen Therapeutics, Inc. (50 trademarks)

3344 North Torrey Pines Court, Suite 200
La Jolla, CA 92037

Entity Type: 03

NALPROPION PHARMACEUTICALS, INC. (10 trademarks)

10 NORTH PARK PLACE, SUITE 201
MORRISTOWN, NJ 07960

Entity Type: 03

Legal Representation

Attorney of Record

Andrew N. Spivak

2,994 trademarks filed View all →

Trademark Details

Filing Date

January 19, 2017

Registration Date

Not Registered

Published for Opposition

June 13, 2017

Goods & Services

Pharmaceutical preparations for use in the treatment of obesity and inducing weight loss

Online pharmaceutical advice, namely, providing online consultation and information for the ordering of pharmaceuticals; Providing information in the field of weight management and the treatment of obesity

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Jan 7, 2019 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Jan 7, 2019 ABN6

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Aug 8, 2018 ASGN

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Aug 6, 2018 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Aug 6, 2018 REAP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 6, 2018 EXRA

SOU EXTENSION 1 GRANTED

Jun 4, 2018 EX1G

SOU EXTENSION 1 FILED

Jun 4, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

Jun 4, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Dec 5, 2017 NOAM

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

Oct 22, 2017 ETOP

EXTENSION OF TIME TO OPPOSE RECEIVED

Jul 12, 2017 ETOF

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 13, 2017 NPUB

PUBLISHED FOR OPPOSITION

Jun 13, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 24, 2017 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

May 10, 2017 PREV

ASSIGNED TO LIE

May 8, 2017 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 31, 2017 CNSA

EXAMINER'S AMENDMENT ENTERED

Mar 30, 2017 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 30, 2017 GNEN

EXAMINERS AMENDMENT E-MAILED

Mar 30, 2017 GNEA

EXAMINERS AMENDMENT -WRITTEN

Mar 30, 2017 CNEA

ASSIGNED TO EXAMINER

Mar 30, 2017 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 26, 2017 NWOS

NEW APPLICATION ENTERED

Jan 23, 2017 NWAP

Related Trademarks

More from this Owner

NALPROPION PHARMACEUTICALS

NALPROPION

More in Same Class

NUTRAXIN

DIA-MAZING

DR · WOLFF

BODYMAINTE

SUPER-BIONICA. GIO-TEEN- DRA. MARIBEL

MESA WAVE